• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种可设计用于检测任何病毒的单电化学生物传感器。

A Single Electrochemical Biosensor Designed to Detect Any Virus.

机构信息

Department of Chemistry, University of Central Florida, Orlando, Florida 32816, United States.

出版信息

Anal Chem. 2024 Apr 16;96(15):5752-5756. doi: 10.1021/acs.analchem.3c05962. Epub 2024 Apr 1.

DOI:10.1021/acs.analchem.3c05962
PMID:38560822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11459061/
Abstract

Viruses are the primary cause of many infectious diseases in both humans and animals. Various testing methods require an amplification step of the viral RNA sample before detection, with quantitative reverse transcription polymerase chain reaction (RT-qPCR) being one of the most widely used along with lesser-known methods like Nucleic Acid Sequence-Based Amplification (NASBA). NASBA offers several advantages, such as isothermal amplification and high selectivity for specific sequences, making it an attractive option for low-income facilities. In this research, we employed a single electrochemical biosensor (E-Biosensor) designed for potentially detecting any virus by modifying the NASBA protocol. In this modified protocol, a reverse primer is designed with an additional 22-nucleotide sequence (tag region) at the 5'-end, which is added to the NASBA process. This tag region becomes part of the final amplicon generated by NASBA. It can hybridize with a single specific E-Biosensor probe set, enabling subsequent virus detection. Using this approach, we successfully detected three different viruses with a single E-Biosensor design, demonstrating the platform's potential for virus detection.

摘要

病毒是导致人类和动物许多传染病的主要原因。各种检测方法都需要对病毒 RNA 样本进行扩增步骤,其中最广泛使用的方法之一是定量逆转录聚合酶链反应(RT-qPCR),还有一些不太知名的方法,如核酸序列扩增(NASBA)。NASBA 具有许多优势,例如等温扩增和对特定序列的高选择性,使其成为低收入设施的一个有吸引力的选择。在这项研究中,我们采用了一种单一的电化学生物传感器(E-Biosensor),通过修改 NASBA 方案来设计用于潜在检测任何病毒的方案。在这个修改后的方案中,在反向引物的 5'-端设计了一个额外的 22 个核苷酸序列(标签区域),该区域被添加到 NASBA 过程中。这个标签区域成为由 NASBA 生成的最终扩增子的一部分。它可以与单个特定的 E-Biosensor 探针组杂交,从而能够进行后续的病毒检测。通过这种方法,我们使用单个 E-Biosensor 设计成功地检测到了三种不同的病毒,证明了该平台用于病毒检测的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a0b/11459061/656c47e9586a/nihms-2022728-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a0b/11459061/33887877c532/nihms-2022728-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a0b/11459061/3433a146b194/nihms-2022728-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a0b/11459061/2026fca23893/nihms-2022728-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a0b/11459061/656c47e9586a/nihms-2022728-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a0b/11459061/33887877c532/nihms-2022728-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a0b/11459061/3433a146b194/nihms-2022728-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a0b/11459061/2026fca23893/nihms-2022728-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a0b/11459061/656c47e9586a/nihms-2022728-f0005.jpg

相似文献

1
A Single Electrochemical Biosensor Designed to Detect Any Virus.一种可设计用于检测任何病毒的单电化学生物传感器。
Anal Chem. 2024 Apr 16;96(15):5752-5756. doi: 10.1021/acs.analchem.3c05962. Epub 2024 Apr 1.
2
Multi-analyte single-membrane biosensor for the serotype-specific detection of Dengue virus.用于登革病毒血清型特异性检测的多分析物单膜生物传感器。
Anal Bioanal Chem. 2004 Sep;380(1):46-53. doi: 10.1007/s00216-004-2724-9. Epub 2004 Jul 28.
3
Ultrasensitive version of nucleic acid sequence-based amplification (NASBA) utilizing a nicking and extension chain reaction system.利用切口和延伸链反应系统的核酸序列扩增(NASBA)超灵敏版本。
Nanoscale. 2021 Jun 24;13(24):10785-10791. doi: 10.1039/d1nr00564b.
4
Characteristics and applications of nucleic acid sequence-based amplification (NASBA).基于核酸序列的扩增技术(NASBA)的特点与应用
Mol Biotechnol. 2002 Feb;20(2):163-79. doi: 10.1385/MB:20:2:163.
5
A rapid and high sensitivity RNA detection based on NASBA and G4-ThT fluorescent biosensor.基于 NASBA 和 G4-ThT 荧光生物传感器的快速高灵敏度 RNA 检测。
Sci Rep. 2022 Jun 16;12(1):10076. doi: 10.1038/s41598-022-14107-y.
6
CRISPR/Cas13a analysis based on NASBA amplification for norovirus detection.基于 NASBA 扩增的 CRISPR/Cas13a 分析用于诺如病毒检测。
Talanta. 2024 Dec 1;280:126725. doi: 10.1016/j.talanta.2024.126725. Epub 2024 Aug 20.
7
Detection of dengue viral RNA using a nucleic acid sequence-based amplification assay.使用基于核酸序列扩增分析的方法检测登革病毒RNA
J Clin Microbiol. 2001 Aug;39(8):2794-8. doi: 10.1128/JCM.39.8.2794-2798.2001.
8
Development and evaluation of nucleic acid sequence based amplification (NASBA) for diagnosis of enterovirus infections using the NucliSens Basic Kit.使用NucliSens Basic试剂盒开发和评估基于核酸序列扩增技术(NASBA)用于肠道病毒感染的诊断。
J Clin Virol. 2002 Feb;24(1-2):117-30. doi: 10.1016/s1386-6532(01)00241-4.
9
NASBA Coupled to Paper Microfluidics for RNA Detection.NASBA 与纸微流控技术偶联用于 RNA 检测。
Methods Mol Biol. 2024;2822:51-64. doi: 10.1007/978-1-0716-3918-4_5.
10
Nucleic acid sequence-based amplification assays for rapid detection of West Nile and St. Louis encephalitis viruses.基于核酸序列的扩增检测法用于快速检测西尼罗河病毒和圣路易斯脑炎病毒。
J Clin Microbiol. 2001 Dec;39(12):4506-13. doi: 10.1128/JCM.39.12.4506-4513.2001.

引用本文的文献

1
Next-Generation Nucleic Acid-Based Diagnostics for Viral Pathogens: Lessons Learned from the SARS-CoV-2 Pandemic.用于病毒病原体的下一代基于核酸的诊断方法:从新冠疫情中吸取的教训
Microorganisms. 2025 Aug 15;13(8):1905. doi: 10.3390/microorganisms13081905.
2
Advances in Wastewater-Based Epidemiology for Pandemic Surveillance: Methodological Frameworks and Future Perspectives.用于大流行监测的基于废水的流行病学进展:方法框架与未来展望。
Microorganisms. 2025 May 21;13(5):1169. doi: 10.3390/microorganisms13051169.
3
Current biosensing strategies based on in vitro T7 RNA polymerase reaction.

本文引用的文献

1
Cost-Effective Modular Biosensor for SARS-CoV-2 and Influenza A Detection.用于 SARS-CoV-2 和流感 A 检测的具有成本效益的模块化生物传感器。
Biosensors (Basel). 2023 Sep 7;13(9):874. doi: 10.3390/bios13090874.
2
A specific and low background nucleic acids sensing strategy based on rolling circle amplification coupled with a magnetic DNA machine.一种基于滚环扩增与磁 DNA 机器偶联的特异且背景低的核酸传感策略。
Chem Commun (Camb). 2023 Aug 17;59(67):10153-10156. doi: 10.1039/d3cc02838k.
3
Isothermal nucleic acid amplification and its uses in modern diagnostic technologies.
基于体外T7 RNA聚合酶反应的当前生物传感策略。
Biotechnol Notes. 2025 Jan 14;6:59-66. doi: 10.1016/j.biotno.2025.01.002. eCollection 2025.
等温核酸扩增及其在现代诊断技术中的应用。
3 Biotech. 2023 Jun;13(6):200. doi: 10.1007/s13205-023-03628-6. Epub 2023 May 18.
4
Real-Time Polymerase Chain Reaction: Current Techniques, Applications, and Role in COVID-19 Diagnosis.实时聚合酶链反应:当前技术、应用及其在 COVID-19 诊断中的作用。
Genes (Basel). 2022 Dec 16;13(12):2387. doi: 10.3390/genes13122387.
5
Evaluation of real-time NASBA assay for the detection of SARS-CoV-2 compared with real-time PCR.实时 NASBA 法与实时 PCR 法检测 SARS-CoV-2 的比较评估。
Ir J Med Sci. 2023 Apr;192(2):723-729. doi: 10.1007/s11845-022-03046-2. Epub 2022 Jun 6.
6
Advances in nucleic acid amplification techniques (NAATs): COVID-19 point-of-care diagnostics as an example.核酸扩增技术(NAATs)的进展:以新冠病毒即时检测诊断为例
Biosens Bioelectron. 2022 Jun 15;206:114109. doi: 10.1016/j.bios.2022.114109. Epub 2022 Feb 26.
7
Assessment of a Smartphone-Based Loop-Mediated Isothermal Amplification Assay for Detection of SARS-CoV-2 and Influenza Viruses.基于智能手机的环介导等温扩增检测 SARS-CoV-2 和流感病毒的评估。
JAMA Netw Open. 2022 Jan 4;5(1):e2145669. doi: 10.1001/jamanetworkopen.2021.45669.
8
Quantifying the relationship between SARS-CoV-2 viral load and infectiousness.量化 SARS-CoV-2 病毒载量与传染性之间的关系。
Elife. 2021 Sep 27;10:e69302. doi: 10.7554/eLife.69302.
9
Rapid electrochemical detection of coronavirus SARS-CoV-2.快速电化学检测冠状病毒 SARS-CoV-2。
Nat Commun. 2021 Feb 5;12(1):802. doi: 10.1038/s41467-021-21121-7.
10
Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant.D614G 刺突变异株出现后,即时进行 SARS-CoV-2 的床边核酸和抗体联合检测
Cell Rep Med. 2020 Sep 22;1(6):100099. doi: 10.1016/j.xcrm.2020.100099. Epub 2020 Sep 1.